DAWN NGO: Open Payments
NPI 1194805978 · AMERICAN FORK, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 15 payments from 9 companies in 2025. Trend: 2023 $2,527 · 2024 $3,433 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Janssen Biotech, Inc. | 3 | $44 |
| ABBVIE INC. | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Gilead Sciences, Inc. | 1 | $27 |
| Celltrion USA Inc. | 1 | $24 |
| Madrigal Pharmaceuticals | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Biocon Biologics Inc | 1 | $14 |
Products named: ENTYVIO, TREMFYA, XIFAXAN, VEGZELMA, REZDIFFRA, CREON, ZENPEP, RINVOQ.
Industry payments across UT — which companies pay providers there.
